Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
61,516
61,516
60,495
58,716
63,281
62,801
Revenue Growth (YoY)
2%
2%
3%
-7%
1%
8%
Cost of Revenue
16,230
16,039
15,783
15,626
18,630
19,348
Gross Profit
45,286
45,477
44,712
43,090
44,651
43,453
Selling, General & Admin
13,838
13,721
13,758
13,518
12,130
12,100
Research & Development
--
--
13,042
13,237
14,053
13,707
Operating Expenses
24,118
23,954
24,625
24,561
24,734
24,922
Other Non Operating Income (Expenses)
-1,456
-1,456
-172
-189
-109
-80
Pretax Income
16,973
16,973
11,793
14,079
16,327
17,398
Income Tax Expense
3,174
3,174
2,606
1,721
2,796
2,463
Net Income
12,880
12,880
8,277
11,498
12,421
13,930
Net Income Growth
56%
56%
-28%
-7%
-11%
-3%
Shares Outstanding (Diluted)
803
803
802
804
808
860
Shares Change (YoY)
0%
0%
0%
-1%
-6%
-1%
EPS (Diluted)
16.04
16.03
10.32
14.3
15.37
16.2
EPS Growth
55%
55%
-28%
-7%
-5%
-2%
Free Cash Flow
10,906
10,906
15,085
11,446
13,251
16,427
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
73.61%
73.92%
73.91%
73.38%
70.55%
69.19%
Operating Margin
34.41%
34.98%
33.2%
31.55%
31.47%
29.5%
Profit Margin
20.93%
20.93%
13.68%
19.58%
19.62%
22.18%
Free Cash Flow Margin
17.72%
17.72%
24.93%
19.49%
20.93%
26.15%
EBITDA
21,471
21,826
20,438
18,865
20,295
18,882
EBITDA Margin
34.9%
35.48%
33.78%
32.12%
32.07%
30.06%
D&A For EBITDA
303
303
351
336
378
351
EBIT
21,168
21,523
20,087
18,529
19,917
18,531
EBIT Margin
34.41%
34.98%
33.2%
31.55%
31.47%
29.5%
Effective Tax Rate
18.7%
18.7%
22.09%
12.22%
17.12%
14.15%
Follow-Up Questions
What are Belle Isle Corp's key financial statements?
According to the latest financial statement (Form-10K), Roche Holding AG has a total asset of $100,703, Net profit of $12,880
What are the key financial ratios for BILSU?
Roche Holding AG's Current ratio is 1.5, has a Net margin is 20.93, sales per share of $76.6.
How is Belle Isle Corp's revenue broken down by segment or geography?
Roche Holding AG largest revenue segment is Roche Pharmaceuticals, at a revenue of 43,297,000,000 in the most earnings release.For geography, Switzerland is the primary market for Roche Holding AG, at a revenue of 747,000,000.
Is Belle Isle Corp profitable?
yes, according to the latest financial statements, Roche Holding AG has a net profit of $12,880
Does Belle Isle Corp have any liabilities?
yes, Roche Holding AG has liability of 66,901
How many outstanding shares for Belle Isle Corp?
Roche Holding AG has a total outstanding shares of 796
Key Stats
Prev.Close
$0.0001
Open
$0.0001
Day's Range
$0.0001 - $0.0001
52 week range
$0.0001 - $0.0001
Volume
229
Avg.Volume
32
Dividend yield
--
EPS (TTM)
--
Market Cap
--
What is BILSU?
The company is headquartered in Dover, Delaware. The company went IPO on 2001-07-25.